COBITOLIMOD

( DrugBank: Cobitolimod / KEGG DRUG: Cobitolimod )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	22

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 10 of 22 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2021-002549-13-PT (EUCTR)	02/08/2022	27/10/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Serbia;United States;Portugal;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
2	EUCTR2021-002549-13-DK (EUCTR)	21/04/2022	24/01/2022	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
3	EUCTR2021-002549-13-AT (EUCTR)	31/03/2022	25/10/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy;France;Australia;Denmark;South Afric ...
4	EUCTR2021-002549-13-NO (EUCTR)	07/03/2022	24/11/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	United States;Portugal;Serbia;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
5	EUCTR2021-002549-13-HR (EUCTR)	24/02/2022	28/02/2022	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
6	EUCTR2021-002549-13-LT (EUCTR)	02/12/2021	06/09/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
7	EUCTR2021-002549-13-SK (EUCTR)	02/12/2021	24/08/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
8	NCT04985968 (ClinicalTrials.gov)	November 24, 2021	22/7/2021	The Efficacy and Safety of Cobitolimodin Participants With Moderate to Severe Active Left-Sided Ulce ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Ulcerative Colitis	Drug: Cobitolimod 250 mg;Drug: Cobitolimod 500 mg;Drug: Placebo	InDex Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	440	Phase 3	United States;Australia;Austria;Belgium;Bosnia and Herzegovina;Brazil;Canada;Croatia;Denmark;France; ...
9	EUCTR2021-002549-13-IT (EUCTR)	22/11/2021	19/10/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimodas an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod Product Code: [-] INN or Proposed INN: Cobitolimod Product Name: Cobitolimod P ...	INDEX PHARMACEUTICALS AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
10	NCT05404074 (ClinicalTrials.gov)	November 22, 2021	17/5/2022	Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis	Pharmacokinetics of Cobitolimod Enemas in Participants With Active Ulcerative Colitis	Ulcerative Colitis	Drug: Cobitolimod 500mg	InDex Pharmaceuticals	NULL	Recruiting	18 Years	N/A	All	6	Phase 1	Sweden

First Previous1 2 3Next Last